|
DE-RISKING ONL1204 TO ENABLE VENTURE CAPITAL INVESTMENT FOR FIRST-IN-HUMAN CLINICAL TRIALS |
2SB1EY022512-03 |
VAN DE GOOR, JANA |
NEI |
2017 |
|
IMPLANTABLE OPTICAL INTRAOCULAR PRESSURE SENSOR FOR IMPROVED GLAUCOMA TREATMENT |
3R44EY021940-02A1S1 |
HASTINGS, JEFFREY TODD |
NEI |
2017 |
|
SAFETY AND EFFICACY OF A TITRATABLE EXTERNAL SHUNT |
3R44EY027244-01S1 |
CAMRAS, LUCINDA |
NEI |
2017 |
|
SAFETY AND EFFICACY OF A TITRATABLE EXTERNAL SHUNT |
4R44EY027244-02 |
CAMRAS, LUCINDA |
NEI |
2017 |
|
MECHANISMS OF PROTEIN AGING IN NORMAL AND CATARACTOUS LENSES |
5R01EY024258-04 |
SCHEY, KEVIN L |
NEI |
2017 |
|
ACTIVATION OF THE ANGIOPOIETIN-TIE2 PATHWAY TO TREAT OCULAR HYPERTENSION AND GLAUCOMA |
5R01EY025799-02 |
QUAGGIN, SUSAN E. |
NEI |
2017 |
|
IMPLANTABLE OPTICAL INTRAOCULAR PRESSURE SENSOR FOR IMPROVED GLAUCOMA TREATMENT |
5R44EY021940-03 |
JARRO SANABRIA, CARLOS ANDRES |
NEI |
2017 |
|
THE BIOLOGY OF NEUROSERPIN |
5R01HL055374-18 |
LAWRENCE, DANIEL A |
NHLBI |
2017 |
|
VAGAL PLASTICITY AFTER CORD INJURY EXACERBATES POST-INFARCT CARDIAC REMODELING |
5R01HL122223-03 |
DICARLO, STEPHEN E |
NHLBI |
2017 |
|
MICRORNA-BASED, CELL-SELECTIVE THERAPY FOR CORONARY ARTERY DISEASE |
5R01HL128411-03 |
TOTARY-JAIN, HANA |
NHLBI |
2017 |